Eyedetec Receives Innovation Award from Eyecelerator Tech Competition
Eyedetec Medical, Inc., the parent company of EyeGiene and the developer of our Insta-Warmth™ Warming Wafer mask system to treat Dry Eye Disease caused by Meibomian Gland Dysfunction, is pleased to have finished in the top six ventures in Eyecelerator’s most recent eye treatment technology competition, “The Winning Pitch Challenge – ASCRS 2022.”
Eyedetec Medical’s newest invention for the treatment of Meibomian Gland Dysfunction (MGD) received an Honorable Mention from the competition judges.
“We were amazed by the quality and diversity of the innovative ideas presented from around the world,” stated Eyecelerator in their announcement of the winners. “ It was an impressive group of submissions. The judges spent considerable time reviewing the pitch decks” before choosing the three finalists and three Honorable Mention awardees.
The device that earned the Eyecelerator honorable mention will use a patented mechanism of action to mobilize lipids from within the glands of the eyelids. This naturally stabilizes and restores the tear film.
Barry J. Linder, MD, MS, President and CEO of Eyedetec Medical, added the following statement:
“We are thrilled to have received this endorsement from the judges that our newest innovation in Dry Eye treatment technology has great potential for improving outcomes and quality of life for patients suffering from this disease.”
Why Innovate New Treatments for Dry Eye Disease?
As many as 30 million Americans suffer from some form of Dry Eye Disease. And Meibomian Gland Dysfunction is implicated in close to 85% of all cases. Dry Eye Disease is incurable and chronic. If left untreated it can cause serious permanent damage to the eye while negatively impacting quality of life. However, ongoing treatment can control symptoms and keep Dry Eye Disease from progressing.
“Given the chronic and incurable nature of Dry Eye, continual innovation around effective treatment is critical,” said Linder. “Patients also need education, so that they share symptoms with their Eye Care Professional during every visit. Too many patients consider Dry Eye symptoms like grittiness, gumminess and, ironically, excessive tearing as normal symptoms of eye strain.”
About Eyedetec Medical, Inc.
Eyedetec Medical specializes in medical devices for the treatment of dry eyes and Meibomian Gland Dysfunction. Its growth is fueled by a passion to deliver product solutions that meet patients’ needs in a convenient, user-friendly, effective, comfortable, and affordable manner.
Eyedetec’s first product, the EyeGiene® Insta-Warmth System™, is a clinically proven medical device indicated for the treatment of Dry Eye Disease.
The company is now developing the next-generation therapy to treat dry eye disease. The new therapy will initiate in doctors’ offices, and then uniquely continue in the patient’s home. Eyedetec’s overarching goal remains providing patients with sustained relief from the discomforts of dry eye.
Eyecelerator is a partnership between ASCRS (American Society of Cataract and Refractive Surgery) and the American Academy of Ophthalmology. It strives to connect entrepreneurs, investors, businesses and ophthalmologists to accelerate ophthalmic innovation and improve patient outcomes. The initiative seeks to spur innovation to help patients and advance the profession by helping doctors engage in an ecosystem of like-minded people.